Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07160166 · ClinicalTrials.gov registry record · NA
Determination of the Oral Irritation Potential of Two Alcohol-Free Rinses
A NA study, sponsored by Kenvue Brands.
- Completed
- Registry status
- NA
- Development phase
- 169
- Enrollment target
NCT07160166: Completed NA study, sponsored by Kenvue Brands.
NCT07160166 is a NA study that has completed, run by Kenvue Brands. The registered enrollment target is 169 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07160166, a NA study, has completed, sponsored by Kenvue Brands.
- COMPLETED
- Registry status
- NA
- Development phase
- 169 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the oral soft and hard tissue tolerance after 14 days of a twice daily regimen of brushing and rinsing with essential oil containing alcohol free mouthwashes versus a control.
Primary Outcome
Change in baseline in oral tolerance based on oral hard and soft tissue exams will be reported. Oral examinations will be conducted to monitor oral hard and soft tissues tolerance to the treatments. Buccal and sublingual mucosae, lips/labial mucosa, mucobuccal gold, gingiva, tongue, hard and soft palate, uvula, oropharynx, teeth and dental restorations will be examined and findings will be recorded in the electronic data capture (EDC) system.
Interventions
- OTHER Prototype 1
- OTHER Prototype 2
- OTHER Marketed Comparator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 169 participants |
| Start Date | 2025-07-11 |
| Est. Completion | 2025-07-30 |
| Phase | NA |
What the finished NCT07160166 record still lists
NCT07160166 is an interventional study that assigns participants to a tested intervention. The registered 169 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 3 interventions - of which Prototype 1 is the first listed.
NCT07160166 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07160166 about?
NCT07160166 is a clinical study titled "Determination of the Oral Irritation Potential of Two Alcohol-Free Rinses". The objective of this study is to evaluate the oral soft and hard tissue tolerance after 14 days of a twice daily regimen of brushing and rinsing with essential oil containing alcohol free mouthwashes versus a control.
What is the current status of trial NCT07160166?
This trial is currently completed. It is a NA study. The enrollment target is 169 participants. The study started on 2025-07-11. Estimated completion is 2025-07-30.
What interventions are being tested in trial NCT07160166?
The interventions under investigation include: Prototype 1 (OTHER), Prototype 2 (OTHER), Marketed Comparator (OTHER).
Who is sponsoring clinical trial NCT07160166?
This trial is sponsored by Kenvue Brands, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07160166's enrollment target sits among peer trials
169 619th of 2000 higher than 1,382 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06191484 · 169 participants · NA
Risk and Resilience to Suicide Following Late-Life Spousal Bereavement
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI